David W. Osborne

Companies

• Arcutis Biotherapeutics, Inc.Chief Technical Officer Jan 30, 2020 to Mar 8, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABArcutis Biotherapeutics, Inc. ARQT268,854 shares²$8.7M at $32.50Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 6, 2023Sold 690 shares at $15.26 of Arcutis Biotherapeutics, Inc.²
• Mar 2, 2023Sold 15 shares at $16.52 of Arcutis Biotherapeutics, Inc.³
• Mar 2, 2023Sold 1,198 shares at $15.82 of Arcutis Biotherapeutics, Inc.³
• Mar 2, 2023Granted 14,900 shares of Arcutis Biotherapeutics, Inc.⁴
• Feb 28, 2023Sold 792 shares at $16.17 of Arcutis Biotherapeutics, Inc.³
• Jul 8, 2022Sold 2,197 shares at $25.41 of Arcutis Biotherapeutics, Inc.⁵
• Apr 21, 2022Sold 2,197 shares at $20.42 of Arcutis Biotherapeutics, Inc.⁶
• Mar 7, 2022Sold 28 shares at $16.44 of Arcutis Biotherapeutics, Inc.⁷
• Mar 4, 2022Sold 828 shares at $16.86 of Arcutis Biotherapeutics, Inc.⁷
• Mar 3, 2022Granted 13,300 shares of Arcutis Biotherapeutics, Inc.⁷
• Mar 1, 2022Sold 775 shares at $17.75 of Arcutis Biotherapeutics, Inc.⁸